Grantclosed🌐 United StatesPAR-23-193

Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)

National Institutes of Health

Details?

Posted: May 19, 2023
Response deadline: Apr 3, 2026, 12:00 AM UTC
Type: Grant
Category: 93.865
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-23-193

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
United States · Nov 6, 2024
Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
United States · Dec 18, 2024
BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
United States · Sep 24, 2024
BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed)
United States · Feb 20, 2024
Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed)
United States · Dec 5, 2023
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
United States · Aug 11, 2023

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.